AARC clinical practice guideline: Transcutaneous monitoring of carbon dioxide and oxygen: 2012

Ruben D. Restrepo, Keith R. Hirst, Leonard Wittnebel, Richard Wettstein

    Research output: Contribution to journalArticle

    46 Citations (Scopus)

    Abstract

    An electronic literature search for articles published between January 1990 and September 2011 was conducted by using the PubMed, CINAHL, SCOPUS, and Cochrane Library databases. The update of this clinical practice guideline is the result of reviewing a total of 124 articles: 3 randomized controlled trials, 103 prospective trials, 1 retrospective study, 3 case studies, 11 review articles, 2 surveys and 1 consensus paper on transcutaneous monitoring (TCM) for PtcO2 and PtcCO2. The following recommendations are made following the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) criteria: (1) Although PtcCO2 has a good correlation with PaCO2 and is a reliable method to evaluate plasma CO2 levels, it is recommended that arterial blood gas values be compared to transcutaneous readings taken at the time of arterial sampling, in order to verify the transcutaneous values, and periodically as dictated by the patient's clinical condition. (2) It is suggested that PtcCO2 may be used in clinical settings where monitoring the adequacy of ventilation is indicated. (3) It is suggested that PtcO2 and PtcCO2 may be used in determining the adequacy of tissue perfusion and monitoring of reperfusion. (4) It is suggested that TCM should be avoided in the presence of increased thickness or edema of the skin and/or subcutaneous tissue where the sensor is applied. (5) It is recommended that sites used for a TCM be changed as often as necessary and that they be alternated and observed to avoid thermal injury. Manufacturer recommendations should be followed.

    Original languageEnglish (US)
    Pages (from-to)1955-1962
    Number of pages8
    JournalRespiratory Care
    Volume57
    Issue number11
    DOIs
    StatePublished - Nov 2012

    Fingerprint

    Transcutaneous Blood Gas Monitoring
    Practice Guidelines
    Carbon Dioxide
    Oxygen
    Subcutaneous Tissue
    PubMed
    Libraries
    Reperfusion
    Ventilation
    Reading
    Edema
    Randomized Controlled Trials
    Retrospective Studies
    Perfusion
    Hot Temperature
    Gases
    Databases
    Skin
    Wounds and Injuries

    Keywords

    • Clinical practice guidelines
    • Hyperbaric oxygen therapy
    • Reperfusion
    • Transcutaneous carbon dioxide
    • Transcutaneous carbon dioxide monitoring
    • Transcutaneous monitoring
    • Transcutaneous oxygen
    • Transcutaneous oxygen monitoring

    ASJC Scopus subject areas

    • Pulmonary and Respiratory Medicine
    • Critical Care and Intensive Care Medicine

    Cite this

    AARC clinical practice guideline : Transcutaneous monitoring of carbon dioxide and oxygen: 2012. / Restrepo, Ruben D.; Hirst, Keith R.; Wittnebel, Leonard; Wettstein, Richard.

    In: Respiratory Care, Vol. 57, No. 11, 11.2012, p. 1955-1962.

    Research output: Contribution to journalArticle

    Restrepo, Ruben D. ; Hirst, Keith R. ; Wittnebel, Leonard ; Wettstein, Richard. / AARC clinical practice guideline : Transcutaneous monitoring of carbon dioxide and oxygen: 2012. In: Respiratory Care. 2012 ; Vol. 57, No. 11. pp. 1955-1962.
    @article{f566fdcde676451f8721cf79503447eb,
    title = "AARC clinical practice guideline: Transcutaneous monitoring of carbon dioxide and oxygen: 2012",
    abstract = "An electronic literature search for articles published between January 1990 and September 2011 was conducted by using the PubMed, CINAHL, SCOPUS, and Cochrane Library databases. The update of this clinical practice guideline is the result of reviewing a total of 124 articles: 3 randomized controlled trials, 103 prospective trials, 1 retrospective study, 3 case studies, 11 review articles, 2 surveys and 1 consensus paper on transcutaneous monitoring (TCM) for PtcO2 and PtcCO2. The following recommendations are made following the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) criteria: (1) Although PtcCO2 has a good correlation with PaCO2 and is a reliable method to evaluate plasma CO2 levels, it is recommended that arterial blood gas values be compared to transcutaneous readings taken at the time of arterial sampling, in order to verify the transcutaneous values, and periodically as dictated by the patient's clinical condition. (2) It is suggested that PtcCO2 may be used in clinical settings where monitoring the adequacy of ventilation is indicated. (3) It is suggested that PtcO2 and PtcCO2 may be used in determining the adequacy of tissue perfusion and monitoring of reperfusion. (4) It is suggested that TCM should be avoided in the presence of increased thickness or edema of the skin and/or subcutaneous tissue where the sensor is applied. (5) It is recommended that sites used for a TCM be changed as often as necessary and that they be alternated and observed to avoid thermal injury. Manufacturer recommendations should be followed.",
    keywords = "Clinical practice guidelines, Hyperbaric oxygen therapy, Reperfusion, Transcutaneous carbon dioxide, Transcutaneous carbon dioxide monitoring, Transcutaneous monitoring, Transcutaneous oxygen, Transcutaneous oxygen monitoring",
    author = "Restrepo, {Ruben D.} and Hirst, {Keith R.} and Leonard Wittnebel and Richard Wettstein",
    year = "2012",
    month = "11",
    doi = "10.4187/respcare.02011",
    language = "English (US)",
    volume = "57",
    pages = "1955--1962",
    journal = "Respiratory Care",
    issn = "0020-1324",
    publisher = "Daedalus Enterprises Inc.",
    number = "11",

    }

    TY - JOUR

    T1 - AARC clinical practice guideline

    T2 - Transcutaneous monitoring of carbon dioxide and oxygen: 2012

    AU - Restrepo, Ruben D.

    AU - Hirst, Keith R.

    AU - Wittnebel, Leonard

    AU - Wettstein, Richard

    PY - 2012/11

    Y1 - 2012/11

    N2 - An electronic literature search for articles published between January 1990 and September 2011 was conducted by using the PubMed, CINAHL, SCOPUS, and Cochrane Library databases. The update of this clinical practice guideline is the result of reviewing a total of 124 articles: 3 randomized controlled trials, 103 prospective trials, 1 retrospective study, 3 case studies, 11 review articles, 2 surveys and 1 consensus paper on transcutaneous monitoring (TCM) for PtcO2 and PtcCO2. The following recommendations are made following the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) criteria: (1) Although PtcCO2 has a good correlation with PaCO2 and is a reliable method to evaluate plasma CO2 levels, it is recommended that arterial blood gas values be compared to transcutaneous readings taken at the time of arterial sampling, in order to verify the transcutaneous values, and periodically as dictated by the patient's clinical condition. (2) It is suggested that PtcCO2 may be used in clinical settings where monitoring the adequacy of ventilation is indicated. (3) It is suggested that PtcO2 and PtcCO2 may be used in determining the adequacy of tissue perfusion and monitoring of reperfusion. (4) It is suggested that TCM should be avoided in the presence of increased thickness or edema of the skin and/or subcutaneous tissue where the sensor is applied. (5) It is recommended that sites used for a TCM be changed as often as necessary and that they be alternated and observed to avoid thermal injury. Manufacturer recommendations should be followed.

    AB - An electronic literature search for articles published between January 1990 and September 2011 was conducted by using the PubMed, CINAHL, SCOPUS, and Cochrane Library databases. The update of this clinical practice guideline is the result of reviewing a total of 124 articles: 3 randomized controlled trials, 103 prospective trials, 1 retrospective study, 3 case studies, 11 review articles, 2 surveys and 1 consensus paper on transcutaneous monitoring (TCM) for PtcO2 and PtcCO2. The following recommendations are made following the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) criteria: (1) Although PtcCO2 has a good correlation with PaCO2 and is a reliable method to evaluate plasma CO2 levels, it is recommended that arterial blood gas values be compared to transcutaneous readings taken at the time of arterial sampling, in order to verify the transcutaneous values, and periodically as dictated by the patient's clinical condition. (2) It is suggested that PtcCO2 may be used in clinical settings where monitoring the adequacy of ventilation is indicated. (3) It is suggested that PtcO2 and PtcCO2 may be used in determining the adequacy of tissue perfusion and monitoring of reperfusion. (4) It is suggested that TCM should be avoided in the presence of increased thickness or edema of the skin and/or subcutaneous tissue where the sensor is applied. (5) It is recommended that sites used for a TCM be changed as often as necessary and that they be alternated and observed to avoid thermal injury. Manufacturer recommendations should be followed.

    KW - Clinical practice guidelines

    KW - Hyperbaric oxygen therapy

    KW - Reperfusion

    KW - Transcutaneous carbon dioxide

    KW - Transcutaneous carbon dioxide monitoring

    KW - Transcutaneous monitoring

    KW - Transcutaneous oxygen

    KW - Transcutaneous oxygen monitoring

    UR - http://www.scopus.com/inward/record.url?scp=84868370105&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84868370105&partnerID=8YFLogxK

    U2 - 10.4187/respcare.02011

    DO - 10.4187/respcare.02011

    M3 - Article

    C2 - 23107301

    AN - SCOPUS:84868370105

    VL - 57

    SP - 1955

    EP - 1962

    JO - Respiratory Care

    JF - Respiratory Care

    SN - 0020-1324

    IS - 11

    ER -